Dr. Tina Wang, MD

Dr. Wang practices at Huntington Hospital - Unit in Pasadena, California.

Dr. Wang's NPI, 1700170743, was assigned on June 7, 2011. Dr. Wang graduated from Joe R. & Teresa Lozano Long School of Medicine in 2010. Dr. Wang holds California license CA121318.

Dr. Wang's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Dr. Wang's primary practice is Huntington Hospital - Unit in Pasadena, California. Dr. Wang is also affiliated with Huntington Hospital. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Wang to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is board certified in hematology by the American Board of Internal Medicine. Dr. Wang is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Wang treats.

CMS data shows 18,448 Medicare services from Dr. Wang across 21 procedure codes in 2024, for 194 Medicare patients. Medicare paid $125,691 for them.

CMS counts 194 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have cancer, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 68, with 72% women.

In 2024, Dr. Wang wrote 393 Medicare Part D claims for 96 patients. 72% of them were for generic drugs. CMS names the drug for 260 of them, across 12 drugs with 11 or more claims each, at $1,120,287 in total drug cost. In 2023, CMS named 196 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 27 papers to Dr. Wang, published from 2011 to 2023. 2020 was the busiest year, with 7. The most frequent topics are DNA Methylation, Aging and Epigenesis, Genetic. Dr. Wang has published most often in Nat Commun. Dr. Wang's most frequent co-authors are Tina Wang, MD, Peter David Adams, MD and Sariah Shanshan Liu, MD, PhD.

CMS Open Payments shows 96 general payments to Dr. Wang from 30 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $412.

Dr. Wang graduated from Joe R. & Teresa Lozano Long School of Medicine in 2010.

Dr. Wang is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.